KANAZAWA, Japan , Sept. 26, 2023 /PRNewswire/ -- Researchers at Kanazawa University report in the Journal of Physical Chemistry Letters high-speed atomic force microscopy studies that shed light on the possible role of the open reading ...
VANCOUVER, BC , Sept. 25, 2023 /PRNewswire/ - In the relentless battle against the ever-evolving COVID-19 pandemic, Gene Bio Medical (GBM), a leading player in the field of medical innovations, is taking center stage with its remarkable ...
ROCHESTER, N.Y. , Sept. 18, 2023 /PRNewswire/ -- OyaGen, Inc. Today the company announced publication in Antiviral Research of studies evaluating the mechanism of action of its proprietary COVID therapeutic in preclinical development. ...
OTTAWA, ON , Sept. 12, 2023 /CNW/ - Health Canada has authorized the use of the Moderna SPIKEVAX™ COVID-19 vaccine targeting the Omicron XBB.1.5 subvariant for people six months of age and older. Health Canada received Moderna's ...
Provides clinical validation for ACM Biolab's Tunable Platform ("ATP™"), ACM Biolab's proprietary polymer-based delivery platform ACM-001 was well tolerated at the recommended dose levels with no serious adverse events and encouraging ...
SHERBROOKE, QC , Aug. 21, 2023 /CNW/ - Immune Biosolutions, a Canadian biotech company based in Sherbrooke , reached a new milestone in developing the first inhaled antibody-based treatment against COVID-19. The prestigious medical ...
The active treatment was four times more effective at reducing fatigue compared to a control, and increased energy levels twice that of the control LONDON , July 19, 2023 /PRNewswire/ -- A promising medical study has just been ...
The Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai) in New York City is pleased to announce that CastleVax, Inc., has completed enrollment and a preliminary analysis of a phase 1 trial of its licensed Newcastle disease virus ...
SAN DIEGO , July 11, 2023 /PRNewswire/ -- The U.S.-Mexico Border Philanthropy Partnership (BPP), the Consulate General of Mexico in San Diego , the California Department of Public Health (CDPH), and Cross Border Xpress (CBX) announce ...
Xulon Press presents a riveting true story to be appreciated by Christians, healthcare workers, and anyone facing illness or struggling with their beliefs and faith. NEWPORT NEWS, Va. , June 15, 2023 /PRNewswire-PRWeb/ -- Authors Dr. ...
Long COVID is draining the economy by billions every year, as workers battle persistent symptoms and face challenges returning to their jobs, reports a new study led by UCL researchers. ...
A new clinical study reveals that an inhibitor of Fas ligand (FasL), also known as CD95 ligand (CD95L), could be the latest game-changing treatment for COVID-19....
Researchers are utilizing AI to detect long COVID symptoms, monitor their progression, and rule out other potential causes. This innovative approach suggests that a substantial 22.8% of the population may be affected by long-term COVID-19 ...
A study led by researchers from the CUNY Graduate School of Public Health and Health Policy (CUNY SPH) and the Barcelona Institute for Global Health (ISGlobal) explores public trust in COVID-19 vaccine science and its influence on vaccine acceptance ...
A new study reveals a concerning link between COVID-19 and dyslipidemia. The pandemic led to a 29% increase in dyslipidemia risk, especially among seniors and people with type 2 diabetes. This condition, characterized by abnormal blood lipid levels, significantly elevates the risk of heart attack and stroke. ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers